Margaret Block

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga et al. · Journal of Clinical Oncology · 2021 · 131 citations · Full text

Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer

Joyce O’Shaughnessy, Kristi McIntyre, Sharon Wilks et al. · JAMA Network Open · 2021 · 33 citations · Full text

Abstract GS01-10: HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast Cancer

Sara A. Hurvitz, Sherene Loi, Joyce O’Shaughnessy et al. · Cancer Research · 2024 · 33 citations

Tumor Biology, Double-blind Phase 3, Breast Oncology +13

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group

Aminah Jatoi, Steven R. Alberts, Nathan R. Foster et al. · Supportive Care in Cancer · 2005 · 32 citations

Medicine, Cancer-associated Weight Loss, Cancer Management +10

Use of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case series

Jonathan M. Davis, Nura El‐Haj, Nimish Shah et al. · Transfusion · 2017 · 29 citations